Skip to main content

Tempus AI

Tempus AI Inc is an American healthcare technology company applying artificial intelligence and precision medicine to precision diagnostics. The company operates a proprietary data technology platform that analyzes genomic sequencing, clinical records, and pathology data to assist physicians in personalized patient care. Main revenue drivers include genomic sequencing diagnostic fees, clinical data licensing fees to pharmaceutical partners, and AI application subscriptions. Tempus AI serves oncologists, clinical research networks, academic medical centers, and biopharmaceutical development companies across North America. The company holds a pioneer position in multi-modal clinical and genomic data aggregation for precision oncology. Headquartered in Chicago, Illinois, Tempus AI Inc is listed on the Nasdaq Stock Market.

9 of the funds FundTelligence covers report a position in Tempus AI.

Legal name
Tempus AI Inc
Sector
Health Care
Country
United States
Funds holding it
9
Exposure themes
Cancer Profiling, Molecular Diagnostics, Precision Medicine & Genomics, Artificial Intelligence, Clinical Data & Precision Medicine, Digital Transformation, Healthcare, Technology Themes

Funds holding Tempus AI

Showing the 8 largest of 9 funds holding it.

Loading...